Page 1

PRODUCT INFORMATION

OXYTOCIN Pro Injection INDICATIONS • Hormone Indicated for Cattle, Horses, Pigs, Sheep, Goats, Dogs and Cats • Uterine inertia, retention of the placenta, agalactia, prevention of haemorrhages after caesarian section or after hard delivery

BENEFITS • Oxytocin hormone for injection to a wide range of animals • IM administration route • For induced parturition, aid to parturition, stimulate involution of the uterus and stimulate milk let down • No withdrawal periods • Quick acting

PACKAGING LIST NO.

UNIT PACKAGE

CASE SIZE

1OXY037

50ml

12

See reverse side for full indications, administration and dosage.

Bimeda® Broomhill Road Tallaght Dublin 24, Ireland Tel: 1850-515253 94

www.bimeda.ie


TECHNICAL INFORMATION

OXYTOCIN Pro Injection CONTENTS:

50 ml Composition: Per ml solution for injection: Active substance: Oxytocin Ph. Eur. 10 I.U. Excipient (preservative): Chlorobutanol Hemihydrate Ph. Eur. 4.75 mg

Target species:

Cattle, pigs, horses, sheep, goats, dogs and cats.

Use

Uterine inertia, retention of the placenta, agalactia, prevention of haemorrhages after caesarean section or hard delivery.

Dosage and administration: For intramuscular or intravenous injection. In mares by slow intravenous infusion (over 1 hour).

Obstetrics:

Cow: 20-50 I.U. per animal by intramuscular injection. Sow: 10-40 I.U. per animal by intramuscular injection. Mare: 20-50 I.U. per animal by intramuscular injection 40-50 I.U. per animal by slow intravenous infusion (over 1 hr) Ewe: 5-30 I.U. per animal by intramuscular injection. Goat: 5-15 I.U. per animal by intramuscular injection. Bitch: 0.5- 3 I.U. per animal depending on bodyweight by intramuscular injection. (administration during delivery). 0.3- 2 I.U. intravenous or 1-10 I.U. by intramuscular injection. (administration post partum). Queen: 0.3- 1 I.U. per animal depending on bodyweight by intramuscular injection. (administration during delivery). 0.15- 1 I.U. intravenous or 1-3 I.U. by intramuscular injection. (administration post partum). The quoted doses are guideline figures only and should in each case be adjusted according to the response of the animals. During or shortly after delivery the minimum dose should be administered in all large animal species; this dosage can be repeated after approximately 30 minutes. The maximum dose should be administered when several hours have past sincedelivery.

Milk letdown:

Cow and mare: 10-40 I.U. Ewe, goat and sow: 5-20 I.U. Queen and bitch: 1-10 I.U. Contra-indications: Do not use oxytocin in case of incomplete dilation of the cervix, any form of obstructive dystocia, known cases of hypersensitivity to the active ingredient. Side-effects: Hypersensitivity reactions sometimes occur.

Withdrawal period: Meat: 0 days Milk: 0 days

during use. Should any apparent growth or discoloration occur, the product should be discarded. Unused product or waste material should be disposed of in accordance with current practice for pharmaceutical waste under national waste disposal regulations. Avoid skin contact with the solution. Keep out of reach of children. For animal treatment only.

LEGAL CATEGORY

P.O.M. Prescription only medicine

VPA 10989/44/1

Storage conditions:

Store between 2 - 8°C, do not freeze.

Shelf life

In-use shelf life is 28 days.

Precautions and warnings:

Oxytocin should not be given simultaneously by more then one route of administration. When oxytocin is administered in excessive dosage, hyperstimulation of the uterus with strong (hypertonic) and/or prolonged (tetanic) contractions, or an increased uterine tone between the contractions may occur, possibly resulting in uterine rupture, cervical and vaginal lacerations,postpartum haemorrhage, placental separation, impaired uterine blood flow, amniotic fluid embolism and foetal trauma including intracranial haemorrhage. Excessive doses of oxytocin may delay parturition by producing uncoordinated uterine contractions, which interfere with the progress of the foetus especially in multiple pregnancies. When oxytocin is used as an aid to parturition, cervical dilation must be confirmed prior to administration to prevent the risk of foetal death and possible uterine rupture. If uterine hyperactivity occurs, oxytocin administration should be immediately discontinued. Adrenaline at physiological levels markedly reduces the effect of oxytocin on the uterus or mammary gland. For this reason the animal should not be frightened when complete oxytocin effect is desired to cause either milk “letdown” or uterine contractions. Avoid the introduction of contamination

www.bimeda.ie 95

1OXY037_Data_Sheet  

http://www.bimeda.ie/docs/iedocs2/1OXY037_Data_Sheet.pdf